Aviva Biosciences Pockets $11.8M in Series B Round

Sep 23, 2002

NEW YORK, Sept. 23 - Startup biochip company Aviva Biosciences today said it has secured $11.8 million in the first closing of a series B round of private-equity financing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Top Five Articles on GenomeWeb Last Week: Early Cancers, ASCO, Circulating Tumor Cells, and More
Genesis Healthcare Raises ¥1.5B in Stock Placement
VelaDx Receives CE-IVD for NGS-Based HIV Genotyping Assay
LabCorp, OmniSeq Sign Distribution Deal
In Brief This Week: Interleukin Genetics, Quest Diagnostics, FDA, and More
IBM, JDRF Collaborate to Research Type 1 Juvenile Diabetes Risk Factors

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Main menu